- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Diffuse Large B-cell Lymphoma (DLBCL)
Total 13912 results
-
Merck Sharp & Dohme LLCRecruitingDiffuse Large B-Cell Lymphoma | DLBCLPoland, United States, France, Israel, Italy, Turkey, Canada, Korea, Republic of, United Kingdom, Thailand, China
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
The Lymphoma Academic Research OrganisationRecruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruiting
-
Ruijin HospitalNot yet recruitingRelapsed or Refractory B-cell LymphomaChina
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B-cell Lymphoma
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Antengene CorporationTerminatedRelapsed/Refractory Diffuse Large B-cell LymphomaChina
-
Seoul National University HospitalAsan Medical Center; Ulsan University Hospital; Inje University; Severance HospitalUnknown
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
Calithera Biosciences, IncTerminatedNon-GCB/ABC Diffuse Large B-Cell Lymphoma | With and Without MyD88 and/or CD79B MutationsUnited States
-
PfizerIncyte Corporation; MorphoSys AGRecruitingDiffuse Large B-Cell LymphomaUnited States, Japan, Puerto Rico, Korea, Republic of
-
Samsung Medical CenterCompletedDiffuse Large B-cell Lymphoma (DLBCL)Korea, Republic of
-
Regeneron PharmaceuticalsAvailableDiffuse Large B-Cell Lymphoma (DLBCL) | Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | B-Cell Non-Hodgkin Lymphoma (NHL) | High-Grade B-Cell Lymphoma (HGBCL)
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Classic Hodgkin Lymphoma | Refractory... and other conditionsUnited States
-
NKBio Co.Ltd.UnknownDiffuse Large B-cell LymphomaKorea, Republic of
-
Zhejiang Genfleet Therapeutics Co., Ltd.RecruitingLarge B-cell LymphomaChina
-
Kami Maddocks, MDPharmacyclics LLC.Active, not recruitingExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent... and other conditionsUnited States
-
Guangdong Provincial People's HospitalUnknownPrimary CNS LymphomaChina
-
George Washington UniversityWithdrawnNon-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
Cell Medica LtdTerminatedLymphoma, Large B-Cell, Diffuse | Hodgkin Lymphoma | Post-transplant Lymphoproliferative DisorderUnited States
-
The Lymphoma Academic Research OrganisationTerminated
-
Chonnam National University HospitalConsortium for Improving Survival of LymphomaUnknown
-
Hackensack Meridian HealthCelgene CorporationCompletedDiffuse Large B Cell LymphomaUnited States
-
PfizerHoffmann-La RocheRecruitingDiffuse Large B-Cell LymphomaUnited States, Taiwan, Japan, Israel
-
University of Michigan Rogel Cancer CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
University Hospital, SaarlandCompletedDLBCL | Old Age; DebilityGermany
-
Istituto Scientifico Romagnolo per lo Studio e...RecruitingDiffuse Large B Cell LymphomaItaly
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
MorphoSys AGCompletedDiffuse Large B Cell LymphomaFrance, Italy, Spain, United States, Austria, Australia, Germany, Korea, Republic of, Canada, Denmark, Taiwan, United Kingdom
-
Asan Medical CenterWithdrawnDiffuse Large B-cell LymphomaKorea, Republic of
-
GenmabAbbVieApproved for marketingPrimary Mediastinal Large B-cell Lymphoma (PMBCL) | Large B-cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-cell Lymphoma (HGBCL) | Grade 3B Follicular Lymphoma
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Peking Union Medical College HospitalRecruitingDiffuse Large B Cell Lymphoma | Central Nervous System LymphomaChina
-
Idera Pharmaceuticals, Inc.CompletedDiffuse Large B Cell LymphomaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...CompletedMantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | Aggressive LymphomaSpain
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
Sun Yat-sen UniversityNot yet recruiting
-
University of RochesterRecruiting
-
Adaptive BiotechnologiesStanford UniversityRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
Fundacion CRIS de Investigación para Vencer el...BTG International Inc.; BioClever 2005 S.L.; Eurofins ADME, S.L.; NTShub, S.L.TerminatedDiffuse Large B-Cell Lymphoma | Drug ToxicitySpain
-
Calithera Biosciences, IncTerminatedDiffuse Large B-cell LymphomaSpain, United States, Italy, Canada, France, United Kingdom
-
National Cancer Institute (NCI)TerminatedRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Refractory Transformed Non-Hodgkin Lymphoma | Recurrent...United States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownDiffuse Large B-cell LymphomaChina
-
Novartis PharmaceuticalsActive, not recruitingDiffuse Large B-cell LymphomaSpain, Germany, Canada, Italy, Hong Kong, China, Japan, France, United States, Singapore
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States
-
PfizerEMD SeronoTerminatedDiffuse Large B-Cell LymphomaUnited States, Belgium, United Kingdom, Spain, Australia, Korea, Republic of, Italy, Poland
-
British Columbia Cancer AgencyHoffmann-La RocheActive, not recruitingLymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaCanada
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States